DataMeds AI, Inc. (MEDS)
1.16
-0.06
(-4.92%)
USD |
NASDAQ |
Nov 06, 10:25
DataMeds AI Net Income (Quarterly) : -18.36M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.36M |
| March 31, 2026 | -7.743M |
| December 31, 2025 | -27.85M |
| September 30, 2025 | -34.32M |
| June 30, 2025 | -6.672M |
| March 31, 2025 | -32.43M |
| December 31, 2024 | -4.332M |
| Date | Value |
|---|---|
| September 30, 2024 | -1.867M |
| June 30, 2024 | -0.5743M |
| March 31, 2024 | -0.0831M |
| December 31, 2023 | -1.076M |
| September 30, 2023 | -0.9033M |
| June 30, 2023 | -0.4288M |
| March 31, 2023 | -0.4875M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | -0.0039M |
| Xcelerate, Inc. | -0.0542M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -0.0214M |
| Vivos Therapeutics, Inc. | -5.523M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.780M |
| Total Expenses (Quarterly) | 20.14M |
| EPS Diluted (Quarterly) | -7.132 |
| Enterprise Value | 33.79M |
| Gross Profit Margin (Quarterly) | -9.80% |
| Profit Margin (Quarterly) | -1.03K% |
| Earnings Yield | -3.73K% |
| Normalized Earnings Yield | -3037.44 |